Integrating Biologically Targeted Therapy in Head and Neck Squamous Cell Carcinomas
- 31 January 2009
- journal article
- review article
- Published by Elsevier BV in Seminars in Radiation Oncology
- Vol. 19 (1), 53-62
- https://doi.org/10.1016/j.semradonc.2008.09.010
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseThe New England Journal of Medicine, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysisInternational Journal of Cancer, 2007
- Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian CarcinomaCancer Research, 2006
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisThe Lancet, 2006
- Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell CarcinomaCancer Research, 2006
- Invadopodia: A guided tourEuropean Journal of Cell Biology, 2006
- Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer CellsClinical Cancer Research, 2005
- Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-AnalysisClinical Cancer Research, 2005
- Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude MiceClinical Cancer Research, 2004